LH Profile
Laboratory Corporation of America Holdings, based in Burlington, North Carolina, operates as a global life sciences company that plays a pivotal role in providing essential information crucial for informed medical decisions. Established in 1994, the company serves a diverse clientele including doctors, hospitals, pharmaceutical firms, researchers, and patients worldwide.
The company operates through two main segments: Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Under Labcorp Diagnostics, it offers an extensive array of diagnostic tests ranging from routine blood chemistry and urinalyses to specialized tests such as genetic-based and esoteric testing. These tests cover a wide spectrum of medical needs including oncology, cardiovascular diseases, infectious diseases, and pharmacogenetics.
Labcorp also provides occupational testing services, medical drug monitoring, chronic disease programs, and kidney stone prevention tests. It leverages online platforms and mobile applications to enable patients to access and monitor their test results conveniently. Moreover, it caters to managed care organizations, healthcare providers, employers, and governmental agencies.
In its Labcorp Drug Development segment, the company offers comprehensive solutions spanning from early-stage research to clinical development and commercial market access for drug development, medical devices, and companion diagnostics. This segment serves pharmaceutical, biotechnology, medical device, and diagnostic companies, reinforcing Labcorp's role in advancing healthcare innovations globally. Through strategic collaborations like the one with Tigerlily Foundation, Labcorp is committed to enhancing clinical trial diversity, particularly focusing on women of color, thereby promoting inclusivity in healthcare research.
|
